A Pilot Study of Ketamine Infusion after Suicide Attempt: New Frontiers in Treating Acute Suicidality in a Real-World Medical Setting
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
Ketamine, in research settings, rapidly reduces suicidal thoughts 2–24 h after a single infusion in patients with high suicidal ideation. In this study, the authors investigate ketamine’s effects on suicidality in a real-world sample of recent suicide attempters on a tertiary-care Consultation-Liaison (CL) psychiatry service. Using an open-label design, 16 transdiagnostic CL patients were recruited, 18–65 years old, to receive a single dose of intravenous ketamine (0.5 mg/kg) in the acute medical setting. All were psychiatrically hospitalized post-infusion. Baseline suicidality and depression measures were compared to ratings taken at 24 h, 5 days, 12 days, and 1, 3 and 6 months post-infusion using paired t-tests. Across all measures, rapid, statistically significant decreases (p’s < 0.001) were observed with large to very large effect sizes (Cohen’s d’s: 1.7–8.8) at acute timepoints (24 h; 5 days). These gains were uniformly maintained to 6 months post-infusion. Open-label ketamine appeared to rapidly and robustly reduced suicidal symptoms in an ultra-high-risk, heterogeneous, real-world sample. Ketamine infusion may therefore be a safe, feasible, viable method to rapidly reduce suicidality among medically hospitalized patients after a suicide attempt, with potentially enduring benefits. The current pilot findings suggest ketamine could be readily integrated into the settings where high-risk CL patients already receive healthcare, with the potential to become an important and novel tool in the treatment of suicidality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous research echoes these results, with multiple studies finding high rates of remission for suicidal ideation after a single ketamine infusion in patients hospitalized for acute suicidal ideation [77][78][79].”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1998) · PubMed · Cited by 10,216
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157 · cited 1×
“Masters-level clinical raters with extensive training and experience in conducting depression treatment research administered the Montgomery–Asberg Depression Rating Scale (MADRS) [42] to assess total depression severity and severity of SI; the MADRS-SI item (item 10) and the Scale for Suicide Ideation (SSI; [43]; add…”
MethodRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 3×
“MADRS = Montgomery–Asberg Depression Rating Scale; SI = suicidal ideation; CSSRS = Columbia Suicide Severity Rating Scale; ASIQ = Adult Suicide Ideation Questionnaire; SSI = Scale for Suicide Ideation; QIDS-SR = Quick Inventory of Depressive Symptoms—Self-Report.”
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research
Franklin, J. C., Ribeiro, J. D., Fox, K. R., Bentley, K. H., Kleiman, E. M., Huang, X., Musacchio, K. M., Jaroszewski, A. C., Chang, B. P., & Nock, M. K. (2017) · Psychological Bulletin · doi:10.1037/bul0000084 · Cited by 3,784
Psychological flexibility as a fundamental aspect of health
Kashdan, T. B., & Rottenberg, J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.001 · Cited by 3,054
Nock, M. K., Borges, G., Bromet, E. J., Cha, C. B., Kessler, R. C., & Lee, S. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn002 · Cited by 2,897
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · cited 1×
“, brain-derived neurotrophic factor (BDNF) expression and signaling) that damage plasticity, fostering neuronal atrophy and synaptic depression, particularly in the PFC and hippocampus [16,17].”
BackgroundNeural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Neurobiology of suicidal behaviour
Mann, J. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1220 · Cited by 1,260 · cited 1×
“The mechanisms of the underlying vulnerability for suicidal behavior are the focus of ongoing research but are thought to include biological, social and psychological underpinnings [51,52].”
BackgroundPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025
Silverman, M. M., Berman, A. L., Sanddal, N. D., O'Carroll, P. W., & Joiner, T. E. (2007) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2007.37.3.264 · Cited by 991
Beyond the tower of Babel: A nomenclature for suicidology
O'Carroll, P. W., Berman, A. L., Maris, R. W., Moscicki, E. K., Tanney, B. L., & Silverman, M. M. (1996) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1996.tb00609.x · Cited by 982
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 739 · cited 3×
“, synaptogenesis) [19], it has been suggested that ketamine might prime patients to respond to other first-line treatments by widening rigid, maladaptive responses and facilitating the acquisition of new skills and/or cognitivebehavioral patterns [39]; however, this theoretical model has not previously been deployed”
BackgroundSelf-citationMeasuring the Suicidal Mind: Implicit Cognition Predicts Suicidal Behavior
Nock, M. K., Park, J. M., Finn, C. T., Deliberto, T. L., Dour, H. J., & Banaji, M. R. (2010) · Psychological Science · doi:10.1177/0956797610364762 · Cited by 624
Suicide Risk in Relation to Psychiatric Hospitalization: Evidence Based on Longitudinal Registers
Qin, P., & Nordentoft, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.427 · Cited by 620
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
Self-citationSilverman, M. M., Berman, A. L., Sanddal, N. D., O'Carroll, P. W., & Joiner, T. E. (2007) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2007.37.3.248 · Cited by 593
DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05327blu · Cited by 564
Impaired decision making in suicide attempters
Jollant, F., Bellivier, F., Leboyer, M., Astruc, B., Torres, S., Verdier, R., Castelnau, D., Malafosse, A., & Courtet, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.304 · Cited by 541
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422
Neuropsychological dysfunction in depressed suicide attempters
Keilp, J. G., Sackeim, H. A., Brodsky, B. S., Oquendo, M. A., Malone, K. M., & Mann, J. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.735 · Cited by 372
Keilp, J. G., Gorlyn, M., Russell, M., Oquendo, M. A., Burke, A. K., Harkavy-Friedman, J., & Mann, J. J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001419 · Cited by 350
Addiction and suicide: A review
Yuodelis‐Flores, C., & Ries, R. K. (2015) · The American Journal on Addictions · doi:10.1111/ajad.12185 · Cited by 342
WISQARS (Web-Based Injury Statistics Query and Reporting System)
(2011) · Choice Reviews Online · doi:10.5860/choice.48-4227 · Cited by 336
A meta-analysis of acute use of alcohol and the risk of suicide attempt
Borges, G., Bagge, C. L., Cherpitel, C. J., Conner, K. R., Orozco, R., & Rossow, I. (2017) · Psychological Medicine · doi:10.1017/s0033291716002841 · Cited by 335
Yovell, Y., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherov, J., Lotan, A., Rigbi, A., & Panksepp, J. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040535 · Cited by 311 · cited 1×
“The time-limited, short-term use of very low dosages of sublingual buprenorphine was associated with decreased suicidal ideation in severely suicidal patients without substance abuse [63].”
BackgroundPsychometric Characteristics of the Adult Suicidal Ideation Questionnaire in College Students
Reynolds, W. M. (1991) · Journal of Personality Assessment · doi:10.1207/s15327752jpa5602_9 · Cited by 299
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001506 · Cited by 297
Self-citationPrediction of suicide ideation and attempts among adolescents using a brief performance-based test.
Nock, M. K., & Banaji, M. R. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.5.707 · Cited by 278
Effect of Zuranolone vs Placebo in Postpartum Depression
Deligiannidis, K. M., Meltzer-Brody, S., Gunduz-Bruce, H., Doherty, J., Jonas, J., Li, S., Sankoh, A. J., Silber, C., Campbell, A. D., Werneburg, B., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1559 · Cited by 277
Chronic Suicidality Among Patients With Borderline Personality Disorder
Paris, J. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.6.738 · Cited by 234
Trial of SAGE-217 in Patients with Major Depressive Disorder
Gunduz-Bruce, H., Silber, C., Kaul, I., Rothschild, A. J., Riesenberg, R., Sankoh, A. J., Li, H., Lasser, R., Zorumski, C. F., Rubinow, D. R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815981 · Cited by 232
Risk of re-attempts and suicide death after a suicide attempt: a survival analysis
Parra-Uribe, I., Blasco-Fontecilla, H., Garcia-Parés, G., Martínez-Naval, L., Valero-Coppin, O., Cebrià-Meca, A., Oquendo, M. A., & Palao-Vidal, D. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1317-z · Cited by 195
Is Hospitalization Useful for Suicidal Patients with Borderline Personality Disorder?
Paris, J. (2004) · Journal of Personality Disorders · doi:10.1521/pedi.18.3.240.35443 · Cited by 193
Dakwar, E., Nunes, E. V., Hart, C. L., Foltin, R. W., Mathew, S. J., Carpenter, K. M., Choi, C. J. “., Basaraba, C. N., Pavlicova, M., & Levin, F. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101123 · Cited by 186 · cited 2×
“For patients with substance-use disorders (SUDs), including those who are critically ill [62], rapid antidepressant effects may allow for better engagement with post-discharge care [33,34].”
BackgroundDakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070684 · Cited by 183
Serious Suicide Attempts: Systematic Review of Psychological Risk Factors
Gvion, Y., & Levi-Belz, Y. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00056 · Cited by 181
Abbar, M., Demattei, C., El-Hage, W., Llorca, P.-M., Samalin, L., Demaricourt, P., Gaillard, R., Courtet, P., Vaiva, G., Gorwood, P., et al. (2022) · BMJ · doi:10.1136/bmj-2021-067194 · Cited by 181 · cited 2×
“Abbar et al. used a single dose of IV ketamine for suicidality in a 2022 double-blind, randomized control trial (RCT) named KETIS [78].”
MethodPhillips, J. L., Norris, S., Talbot, J., Hatchard, T., Ortiz, A., Birmingham, M., Owoeye, O., Batten, L. A., & Blier, P. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0570-x · Cited by 139 · cited 1×
“However, this study excluded those with substance-use disorders and BMI > 35 [73].”
Weisz, J. R., Chu, B. C., & Polo, A. J. (2004) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bph085 · Cited by 137
Wilkinson, S. T., Wright, D., Fasula, M. K., Fenton, L., Griepp, M., Ostroff, R. B., & Sanacora, G. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457960 · Cited by 122
The emergency medicine management of severe alcohol withdrawal
Long, D., Long, B., & Koyfman, A. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.02.002 · Cited by 118
A Word to the Wise About Ketamine
Schatzberg, A. F. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101434 · Cited by 109
Predictors of re-attempt in a cohort of suicide attempters: A survival analysis
Irigoyen, M., Porras-Segovia, A., Galván, L., Puigdevall, M., Giner, L., De Leon, S., & Baca-García, E. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.050 · Cited by 96
A Word to the Wise About Intranasal Esketamine
Schatzberg, A. F. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19040423 · Cited by 96 · cited 1×
“, premature discharge from the inpatient stay; increased substance use, including ketamine abuse) [71,72] and to understand whether ketamine’s rapid effects alter longerterm trajectories and behaviors in a meaningful way (e.”
BackgroundWilkinson, S. T., Holtzheimer, P. E., Gao, S., Kirwin, D. S., & Price, R. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.004 · Cited by 95 · cited 1×
“, synaptogenesis) [19], it has been suggested that ketamine might prime patients to respond to other first-line treatments by widening rigid, maladaptive responses and facilitating the acquisition of new skills and/or cognitivebehavioral patterns [39]; however, this theoretical model has not previously been deployed”
BackgroundSelf-citationExisting and Novel Biological Therapeutics in Suicide Prevention
Griffiths, J. J., Zarate, C. A., & Rasimas, J. J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.06.012 · Cited by 93
Neuropsychological deficits in past suicide attempters with varying levels of depression severity
Keilp, J. G., Beers, S. R., Burke, A. K., Melhem, N. M., Oquendo, M. A., Brent, D. A., & Mann, J. J. (2014) · Psychological Medicine · doi:10.1017/s0033291714000786 · Cited by 88
Domany, Y., Shelton, R. C., & McCullumsmith, C. B. (2020) · Depression and Anxiety · doi:10.1002/da.22975 · Cited by 84
Suicide after discharge from psychiatric inpatient care: a case-control study in Hong Kong
Yim, P. H. W., Yip, P. S. F., Li, R. H. Y., Dunn, E. L. W., Yeung, W. S., & Miao, Y. K. (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01299.x · Cited by 83
Risk-Sensitive Decision-Making Deficit in Adolescent Suicide Attempters
Ackerman, J. P., McBee-Strayer, S. M., Mendoza, K., Stevens, J., Sheftall, A. H., Campo, J. V., & Bridge, J. A. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0041 · Cited by 69
Pradhan, B., Mitrev, L., Moaddell, R., & Wainer, I. W. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.03.006 · Cited by 63
Rodriguez, C. I., Wheaton, M., Zwerling, J., Steinman, S. A., Sonnenfeld, D., Galfalvy, H., & Simpson, H. B. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15l10138 · Cited by 62
Ensuring mental health access for vulnerable populations in COVID era
Egede, L. E., Ruggiero, K. J., & Frueh, B. C. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.011 · Cited by 62
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
Can, A., Hermens, D. F., Dutton, M., Gallay, C. C., Jensen, E., Jones, M., Scherman, J. K., Beaudequin, D. A., Yang, C., Schwenn, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01230-z · Cited by 58
Shiroma, P. R., THURAS, P. D., Wels, J., Erbes, C. R., Kehle‐Forbes, S., & Polusny, M. A. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20l13406 · Cited by 53
Testing mood-activated psychological markers for suicidal ideation
Cha, C. B., O'Connor, R. C., Kirtley, O., Cleare, S., Wetherall, K., Eschle, S., Tezanos, K. M., & Nock, M. K. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000358 · Cited by 47
Watts, B. V., Young-Xu, Y., Mills, P. D., DeRosier, J. M., Kemp, J., Shiner, B., & Duncan, W. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1514 · Cited by 46
Test–retest stability on the WRAT-3 reading subtest in geriatric cognitive evaluations
Ashendorf, L., Jefferson, A. L., Green, R. C., & Stern, R. A. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802375557 · Cited by 42
Kraft, C. M., Morea, P., Teresi, B. B., Platts‐Mills, T. F., Blazer, N. L., Brice, J. H., & Strain, A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.11.021 · Cited by 37
Domany, Y., & McCullumsmith, C. B. (2021) · Archives of Suicide Research · doi:10.1080/13811118.2021.1878078 · Cited by 35
Faden, J., & Citrome, L. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320968658 · Cited by 34
The Vital Role of a Full Continuum of Psychiatric Care Beyond Beds
Pinals, D. A., & Fuller, D. A. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900516 · Cited by 32
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study
Bullock, A. E., Kaul, I., Li, S., Silber, C., Doherty, J., & Kanes, S. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117277 · Cited by 31
Smith, J. L., Nadai, A. S. D., Storch, E. A., Langland‐Orban, B., Pracht, E. E., & Petrila, J. P. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500283 · Cited by 29
Conner, K. R., Kearns, J. C., Esposito, E. C., Pizzarello, E., Wiegand, T. J., Britton, P. C., Michel, K., Gysin-Maillart, A., & Goldston, D. B. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.07.002 · Cited by 27
Bullock, A. E., Gunduz‐Bruce, H., Zammit, G. K., Qin, M., Li, H., Sankoh, A. J., Silber, C., Kanes, S., Jonas, J. M., & Doherty, J. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2806 · Cited by 20
Barbosa, M. G., Delfino, R. S., Sarin, L. M., & Jackowski, A. P. (2020) · Palliative Medicine · doi:10.1177/0269216320910351 · Cited by 18
New trends in pharmacological control of neuropsychiatric symptoms of dementia
Scuteri, D., Corasaniti, M. T., Tonin, P., Nicotera, P., & Bagetta, G. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.002 · Cited by 18
Substance Use Disorder and Suicide Attempt Among People Who Report Compromised Health
Prince, J. D. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1323925 · Cited by 16
Treu, C. N., Groth, C. M., & Patel, J. H. (2017) · The Journal of Critical Care Medicine · doi:10.1515/jccm-2017-0026 · Cited by 12
Herniman, S. E., Cotton, S., Allott, K., Phillips, L., Wood, S. J., Liemburg, E. J., Castelein, S., Veling, W., Bruggeman, R., & Knegtering, H. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.015 · Cited by 11
Cited by
Ketamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
Feng, W., Chen, C., Zeng, Y., & Zhang, B. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111152 · Cited by 11
Making Progress in Clinical Trials for Suicide Prevention: A Review
Wilkinson, S. T., Bryan, C. J., Alphs, L. D., Canuso, C. M., Ostacher, M. J., Price, R. B., Bloch, M. H., Zarate, C. A., & Rhee, T. G. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4810 · Cited by 7
Self-citationNew pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality
Kotzalidis, G. D., Fiaschè, F., Alcibiade, A., Monti, L., Segni, F. D., Mazza, M., & Sani, G. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2334425 · Cited by 4
Tang, W., Jiang, W.-W., Que, W., Zhang, W.-Q., Chen, H.-L., & Zhou, L.-J. (2026) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796025100371 · Cited by 3
Metadata
- Authors
- Shivanekar, S., Gopalan, P., Pizon, A., Spotts, C., Cruz, N., Lightfoot, M., Rohac, R., Baumeister, A., Griffo, A., Panny, B., Kucherer, S., Israel, A., Rengasamy, M., & Price, R.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Price, Rebecca
- ORCID
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2022-10-24
- Volume
- 19
- Issue
- 21
- Pages
- 13792
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC9656070
- OpenAlex
- W4307160388
- Cited by
- 8
- References
- 76
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Laurel Zaks Memorial Research Award
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- ketamine, suicide attempts, suicidality, suicidal ideation, psychosomatic medicine, inpatient psychiatric hospitalization, depression, rapid-acting antidepressants, real-world treatment
- MeSH terms
- Adolescent, Adult, Aged, Humans, Ketamine, Middle Aged, Pilot Projects, Suicide, Suicide, Attempted, Young Adult, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.